Cocrystal Pharma Inc. (NASDAQ: COCP) Stock Information | RedChip

Cocrystal Pharma Inc. (NASDAQ: COCP)


$2.1850
-0.0650 ( -2.89% ) 6.4K

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Market Data


Open


$2.1850

Previous close


$2.2500

Volume


6.4K

Market cap


$21.98M

Day range


$2.1060 - $2.2750

52 week range


$1.3250 - $3.1000

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Nov 13, 2024
10-q Quarterly Reports 58 Nov 13, 2024
8-k 8K-related 15 Oct 31, 2024
4 Insider transactions 1 Oct 11, 2024
4 Insider transactions 1 Oct 11, 2024
4 Insider transactions 1 Oct 11, 2024
4 Insider transactions 1 Oct 11, 2024
4 Insider transactions 1 Oct 11, 2024
4 Insider transactions 1 Oct 11, 2024
4 Insider transactions 1 Oct 11, 2024

Latest News